Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Mg2+ binding triggers rearrangement of the IM30 ring structure, resulting in augmented exposure of hydrophobic surfaces competent for membrane binding.

Heidrich J, Junglas B, Grytsyk N, Hellmann N, Rusitzka K, Gebauer W, Markl J, Hellwig P, Schneider D.

J Biol Chem. 2018 May 25;293(21):8230-8241. doi: 10.1074/jbc.RA117.000991. Epub 2018 Apr 4.

2.

What is Vipp1 good for?

Junglas B, Schneider D.

Mol Microbiol. 2018 Apr;108(1):1-5. doi: 10.1111/mmi.13924. Epub 2018 Feb 23.

PMID:
29418020
3.

The regulation of connective tissue growth factor expression influences the viability of human trabecular meshwork cells.

Kuespert S, Junglas B, Braunger BM, Tamm ER, Fuchshofer R.

J Cell Mol Med. 2015 May;19(5):1010-20. doi: 10.1111/jcmm.12492. Epub 2015 Feb 20.

4.

The prostaglandin f2α analog fluprostenol attenuates the fibrotic effects of connective tissue growth factor on human trabecular meshwork cells.

Fuchshofer R, Kuespert S, Junglas B, Tamm ER.

J Ocul Pharmacol Ther. 2014 Mar-Apr;30(2-3):237-45. doi: 10.1089/jop.2013.0205. Epub 2014 Feb 27.

PMID:
24576038
5.

The role of plasmalemma vesicle-associated protein (PLVAP) in endothelial cells of Schlemm's canal and ocular capillaries.

Herrnberger L, Ebner K, Junglas B, Tamm ER.

Exp Eye Res. 2012 Dec;105:27-33. doi: 10.1016/j.exer.2012.09.011. Epub 2012 Oct 9.

PMID:
23063469
6.

Connective tissue growth factor causes glaucoma by modifying the actin cytoskeleton of the trabecular meshwork.

Junglas B, Kuespert S, Seleem AA, Struller T, Ullmann S, Bösl M, Bosserhoff A, Köstler J, Wagner R, Tamm ER, Fuchshofer R.

Am J Pathol. 2012 Jun;180(6):2386-403. doi: 10.1016/j.ajpath.2012.02.030. Epub 2012 Apr 26.

PMID:
22542845
7.

Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury.

Fuchshofer R, Ullmann S, Zeilbeck LF, Baumann M, Junglas B, Tamm ER.

Histochem Cell Biol. 2011 Sep;136(3):301-19. doi: 10.1007/s00418-011-0844-9. Epub 2011 Aug 4.

PMID:
21814837
8.

CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration.

Braig S, Wallner S, Junglas B, Fuchshofer R, Bosserhoff AK.

Br J Cancer. 2011 Jul 12;105(2):231-8. doi: 10.1038/bjc.2011.226. Epub 2011 Jun 14.

9.

Different collagen types define two types of idiopathic epiretinal membranes.

Kritzenberger M, Junglas B, Framme C, Helbig H, Gabel VP, Fuchshofer R, Tamm ER, Hillenkamp J.

Histopathology. 2011 May;58(6):953-65. doi: 10.1111/j.1365-2559.2011.03820.x. Epub 2011 Apr 12.

PMID:
21480957
10.

Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells.

Junglas B, Yu AH, Welge-Lüssen U, Tamm ER, Fuchshofer R.

Exp Eye Res. 2009 Jun;88(6):1065-75. doi: 10.1016/j.exer.2009.01.008. Epub 2009 Feb 7.

PMID:
19450452
11.

The interaction of Nanoarchaeum equitans with Ignicoccus hospitalis: proteins in the contact site between two cells.

Burghardt T, Junglas B, Siedler F, Wirth R, Huber H, Rachel R.

Biochem Soc Trans. 2009 Feb;37(Pt 1):127-32. doi: 10.1042/BST0370127.

PMID:
19143616
12.

Ignicoccus hospitalis and Nanoarchaeum equitans: ultrastructure, cell-cell interaction, and 3D reconstruction from serial sections of freeze-substituted cells and by electron cryotomography.

Junglas B, Briegel A, Burghardt T, Walther P, Wirth R, Huber H, Rachel R.

Arch Microbiol. 2008 Sep;190(3):395-408. doi: 10.1007/s00203-008-0402-6. Epub 2008 Jul 12.

13.

Nanoarchaeum equitans and Ignicoccus hospitalis: new insights into a unique, intimate association of two archaea.

Jahn U, Gallenberger M, Paper W, Junglas B, Eisenreich W, Stetter KO, Rachel R, Huber H.

J Bacteriol. 2008 Mar;190(5):1743-50. doi: 10.1128/JB.01731-07. Epub 2007 Dec 28.

14.

The dominating outer membrane protein of the hyperthermophilic Archaeum Ignicoccus hospitalis: a novel pore-forming complex.

Burghardt T, Näther DJ, Junglas B, Huber H, Rachel R.

Mol Microbiol. 2007 Jan;63(1):166-76. Epub 2006 Dec 5.

Supplemental Content

Loading ...
Support Center